Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1430-1438

  Ren, Yu ^a   Zheng, Jianjian ^b   Yao, Xuping ^a   Weng, Guobin ^c   Wu, Ling ^d  

^a Ningbo Urology and Nephrology Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c Ningbo Yinzhou People's Hospital   (China)

^d Ningbo Women and Children's Hospital   (China)

Author keywords

Apoptosis; Phosphodiesterase type 5; Protein kinase G signaling; Renal carcinoma cell; catenin

Indexed keywords

8 BROMO CYCLIC GMP; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA CATENIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYCLIN D1; KT 5823; MESSENGER RNA; PHOSPHODIESTERASE V; PROTEIN P21; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR SP1; 8-BROMOCYCLIC GMP; ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; CYCLIC GMP; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PHOSPHODIESTERASE V INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SULINDAC; SULINDAC SULFONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CARBAZOLES; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHODIESTERASE 5 INHIBITORS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; SULINDAC;

EID: 84907190913     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1925     Document Type: Article

References (30)

1. Rini BI, Rathmell WK and Godley P: Renal cell carcinoma. Curr Opin Oncol 20: 300-306, 2008.
2. Escudier B: Chemo-immunotherapy in RCC: the end of a story. Lancet 375: 613-614, 2010.
3. Mulders PF, Brouwers AH, Hulsbergen-van der Kaa CA, et al: Guideline 'Renal cell carcinoma'. Ned Tijdschr Geneeskd 152: 376-380, 2008 (In Dutch).
4. Zhu B and Strada SJ: The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels. Curr Top Med Chem 7: 437-454, 2007.
5. Thompson WJ, Piazza GA, Li H, et al: Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 60: 3338-3342, 2000.
6. Piazza GA, Thompson WJ, Pamukcu R, et al: Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res 61: 3961-3968, 2001.
7. Zhu B, Vemavarapu L, Thompson WJ and Strada SJ: Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells. J Cell Biochem 94: 336-350, 2005.
8. Lim JT, Piazza GA, Han EK, et al: Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol 58: 1097-1107, 1999.
9. Tinsley HN, Gary BD, Keeton AB, et al: Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G. Mol Cancer Ther 8: 3331-3340, 2009.
10. Tinsley HN, Gary BD, Keeton AB, et al: Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/beta-catenin-mediated transcription in human breast tumor cells. Cancer Prev Res (Phila) 4: 1275-1284, 2011.
11. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
12. Li H, Liu L, David ML, et al: Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 downregulation. Biochem Pharmacol 64: 1325-1336, 2002.
13. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
14. Deguchi A, Thompson WJ and Weinstein IB: Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 64: 3966-3973, 2004.
15. Carlson B, Lahusen T, Singh S, et al: Downregulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res 59: 4634-4641, 1999.
16. Liu L, Li H, Underwood T, et al: Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther 299: 583-592, 2001.
17. Kwon IK, Wang R, Thangaraju M, et al: PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 29: 3423-3434, 2010.
18. Soh JW, Mao Y, Kim MG, et al: Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res 6: 4136-4141, 2000.
19. Hofmann F: The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280: 1-4, 2005.
20. Das A, Xi L and Kukreja RC: Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283: 29572-29585, 2008.
21. Peruzzi B and Bottaro DP: Beta-catenin signaling: linking renal cell carcinoma and polycystic kidney disease. Cell Cycle 5: 2839-2841, 2006.
22. Thompson MD and Monga SP: WNT/beta-catenin signaling in liver health and disease. Hepatology 45: 1298-1305, 2007.
23. Chesire DR and Isaacs WB: Beta-catenin signaling in prostate cancer: An early perspective. Endocr Relat Cancer 10: 537-560, 2003.
24. Stein U, Arlt F, Smith J, et al: Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia 13: 131-144, 2011.
25. Li H, Pamukcu R and Thompson WJ: beta-Catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther 1: 621-625, 2002.
26. Ueda M, Gemmill RM, West J, et al: Mutations of the beta-and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85: 64-68, 2001.
27. Tarmin L, Yin J, Harpaz N, et al: Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55: 2035-2038, 1995.
28. Lewis A, Davis H, Deheragoda M, et al: The C-terminus of Apc does not influence intestinal adenoma development or progression. J Pathol 226: 73-83, 2012.
29. Whitehead CM, Earle KA, Fetter J, et al: Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Mol Cancer Ther 2: 479-488, 2003.
30. Saikawa Y, Kubota T, Otani Y, et al: Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells. Jpn J Cancer Res 92: 1102-1109, 2001.